Search Results

Follow-On Biologics: Intellectual Property and Innovation Issues
This report presents Intellectual Property and Innovation issues related to Follow-On Biologics.
Mayo v. Prometheus: Implications for Patents, Biotechnology, and Personalized Medicine
Report that reviews the Supreme Court's 2012 Mayo Collaborative Services v. Prometheus Laboratories decision (wherein the court held that a patent claiming a method of optimizing therapies for autoimmune disease was invalid) and briefly consider its implications for innovation and public health.
Back to Top of Screen